113 related articles for article (PubMed ID: 38232124)
1. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.
Lu F; Day L; Gao SJ; Lieberman PM
J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
[TBL] [Abstract][Full Text] [Related]
5. Nucleolin Regulates the Expression of Kaposi's Sarcoma-Associated Herpesvirus' Latency-Associated Nuclear Antigen through G-Quadruplexes in the mRNA.
Zareie AR; Verma SC
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140679
[TBL] [Abstract][Full Text] [Related]
6. KSHV genome harbors both constitutive and lytically induced enhancers.
Roy Chowdhury N; Gurevich V; Shamay M
J Virol; 2024 May; ():e0017924. PubMed ID: 38695538
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells.
Haddad CO; Kalt I; Shovman Y; Xia L; Schlesinger Y; Sarid R; Parnas O
Virol J; 2021 Mar; 18(1):56. PubMed ID: 33731154
[TBL] [Abstract][Full Text] [Related]
8. Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA.
Ye X; Guerin LN; Chen Z; Rajendren S; Dunker W; Zhao Y; Zhang R; Hodges E; Karijolich J
Cell Rep; 2024 Mar; 43(3):113888. PubMed ID: 38416644
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA.
Gan J; Wang C; Jin Y; Guo Y; Xu F; Zhu Q; Ding L; Shang H; Wang J; Wei F; Cai Q; Robertson ES
Proteomics; 2015 Jun; 15(12):2023-37. PubMed ID: 25894481
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins.
Chen W; Sin SH; Wen KW; Damania B; Dittmer DP
PLoS Pathog; 2012; 8(11):e1003048. PubMed ID: 23209418
[TBL] [Abstract][Full Text] [Related]
11. Elevated iNOS and 3'-nitrotyrosine in Kaposi's Sarcoma tumors and mouse model.
Vladimirova O; Soldan S; Su C; Kossenkov A; Ngalamika O; Tso FY; West JT; Wood C; Lieberman PM
Tumour Virus Res; 2023 Jun; 15():200259. PubMed ID: 36863485
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection in three-dimensional air-liquid interface culture model.
Jung KL; Choi UY; Park A; Foo SS; Kim S; Lee SA; Jung JU
PLoS Pathog; 2022 Aug; 18(8):e1010775. PubMed ID: 35976902
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the KSHV and EBV lytic cycles to tumourigenesis.
Manners O; Murphy JC; Coleman A; Hughes DJ; Whitehouse A
Curr Opin Virol; 2018 Oct; 32():60-70. PubMed ID: 30268927
[TBL] [Abstract][Full Text] [Related]
14. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.
Myoung J; Ganem D
J Clin Invest; 2011 Mar; 121(3):1130-40. PubMed ID: 21339648
[TBL] [Abstract][Full Text] [Related]
15. Guinea pig herpes like virus is a gamma herpesvirus.
Stanfield BA; Ruiz E; Chouljenko VN; Kousoulas KG
Virus Genes; 2024 Apr; 60(2):148-158. PubMed ID: 38340271
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection.
Li S; Wang M; Van Sciver N; Szymula A; Tumuluri VS; George A; Ramachandran A; Raina K; Costa CN; Zhao B; Kazemian M; Simas JP; Kaye KM
PLoS Pathog; 2024 Jan; 20(1):e1011907. PubMed ID: 38232124
[TBL] [Abstract][Full Text] [Related]
17. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
